Metabolic syndrome; frequency and its relationship with variable parameters in chronic obstructive pulmonary disease

[1] Cameron AJ(2004)The metabolic syndrome:prevalence in worldwide populations Endocrinol Metab Clin North Am 33 351-375

[2] Shaw JE(2002)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment panel III) final report Circulation 106 3143-3421

[3] Zimmet PZ(2007)Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease:GOLD executive summary Am J Respir Crit Care Med 176 532-555

[4] Rabe KF(2006)Mortality in COPD:role of comorbidities Eur Respir J 28 1245-1257

[5] Hurd S(2007)Systemic effects of chronic obstructive pulmonary disease:what we know and what we don’t know (but should) Proc Am Thorac Soc 4 522-525

[6] Anzueto A(2007)From COPD to chronic systemic inflammatory syndrome? Lancet 370 797-799

[7] Barnes PJ(2005)Metabolic syndrome in patients with chronic obstructive pulmonary disease J Cardiopulm Rehabil 25 226-232

[8] Buist SA(2002)Body mass index & risk of COPD Chest 121 370-376

[9] Calverley P(2016)Metabolic syndrome and the lung Chest 149 1525-1534

[10] Sin DD(2010)Association between airflow obstruction and the metabolic syndrome and its components in Japanese men Intern Med 49 2093-2099

[1] Cameron AJ(2004)The metabolic syndrome:prevalence in worldwide populations Endocrinol Metab Clin North Am 33 351-375

[2] Shaw JE(2002)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment panel III) final report Circulation 106 3143-3421

[3] Zimmet PZ(2007)Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease:GOLD executive summary Am J Respir Crit Care Med 176 532-555

[4] Rabe KF(2006)Mortality in COPD:role of comorbidities Eur Respir J 28 1245-1257

[5] Hurd S(2007)Systemic effects of chronic obstructive pulmonary disease:what we know and what we don’t know (but should) Proc Am Thorac Soc 4 522-525

[6] Anzueto A(2007)From COPD to chronic systemic inflammatory syndrome? Lancet 370 797-799

[7] Barnes PJ(2005)Metabolic syndrome in patients with chronic obstructive pulmonary disease J Cardiopulm Rehabil 25 226-232

[8] Buist SA(2002)Body mass index & risk of COPD Chest 121 370-376

[9] Calverley P(2016)Metabolic syndrome and the lung Chest 149 1525-1534

[10] Sin DD(2010)Association between airflow obstruction and the metabolic syndrome and its components in Japanese men Intern Med 49 2093-2099